Opinion Article - Research and Reports on Genetics (2022) Volume 4, Issue 4

The role of viral genomic prediction and epigenomic regulation.

Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, Netherlands

*Corresponding Author:

Eldamartinez Martinez
Department of Primary and Community Care
Radboud University Medical Center
Nijmegen, Netherlands
E-mail: eldamartinez@Martinez

Received: 01-Jul-2022, Manuscript No. AARGS-22-116; Editor assigned: 04-Jul-2022, Pre QC No. AARGS-22-116(PQ); Reviewed: 18-Jul-2022, QC No. AARGS-22-116; Revised: 21-Jul-2022, Manuscript No. AARGS-22-116(R); Published: 25-Jul-2022, DOI: 10.35841/aargs-4.4.116

Citation: Martinez E. The role of viral genomic prediction and epigenomic regulation. J Res Rep Genet.2022;4(4):116

Abstract

Keywords

Neurological analysis, Neurodevelopmental disorders, Neuroscience.

Introduction

The use of genomic medicine in clinical care is rapidly evolving, moving from research discovery to clinical practice, providing patients with the possibility of timely and accurate diagnosis and personalized treatment planning. Complex healthcare systems are critical due in part to the interdisciplinary and coordinated approach required by different healthcare team’s laboratory technicians, clinical geneticists, genetic consultants, data analysts etc. Challenges will be presented. It arises to enable effective and sustainable translation and implementation of genomics research into clinical care [1,2].

Since the establishment of the Central Dogma of Molecular Biology we have an increasing complexity of molecules that enable life-sustaining specific gene expression programs based on this core process. I'm surprised at that. After the discovery of non-coding RNA, transfer RNA, and ribosomal RNA messenger (m) RNA identified in the provided a template for protein synthesis. The ncRNA family grew with the identification of nucleolar RNA and nucleolar RNA in the but in the nucleolar RNA. Did not grow until was discovered, and small interferants [3].

Health inequalities defined as everyone who has the opportunity to live as healthy as possible, have long been a public health priority. Attention to disparities in health outcomes during the COVID-19 pandemic fuels interest in public health behavior to promote health equity health inequalities affect length and quality of life. Morbidity, disability and mortality; severity of illness; access to health care and treatment. Health fairness in genomic medicine can be viewed as "global applicability of genomic knowledge, fair and equal access to genomic services such as testing and counseling, and fair practice of genomic medicine."

Use an evidence-based structured approach to support the changes you actually need. Theories, frameworks, and or models guide the process regardless of whether it guides the entire implementation process, identifies potential causal mechanisms and relationships, or provides a schematic plan to follow. If the use of evidence-based structured approaches is not properly considered and integrated, the success of implementation work will be limited, leading to resource waste, ineffective communication processes, and potential errors in translation studies. All of which limit the impact on public health [4].

The use evidence-based approach provides the best support, especially for successful implementations of genomic medicine, with the interdisciplinary and coordinated approach needed across different healthcare teams. First, the taxonomy described by Nilsen understands and or explains the structured implementation approach outlined in the study, whose purpose is to describe guide the implementation process, and to affect implementation results. Categorize according to whether it is to evaluate the implementation. Identifying objectives guides the proper selection and application of specific structured approaches to implementation and or implementation science and facilitates interdisciplinary communication between researchers.

Here we review advances over the last years in understanding the function of lncRNAs as regulators of gene expression and cellular function. The basis of protein-mediated gene expression, which regulates mRNA production, turnover, and regulates transcriptional and post-transcriptional processes that affect translation, using several selected examples primarily from the mammalian world [5].

Conclusion

Presents a new image with targeted and basic genomic control. Layered on top of this layer is an epigenome program that modifies genomic regulation by altering DNA chemistry, RNA chemistry, and chromatin composition. lncRNA proposes to create an additional dimension of regulation that overlaps the genomic and epigenome layers. In this dimension, lncRNAs form scaffolds, organize regions of DNA, regulate transcription, recruit RNA and cytoplasmic factors to sites of post-transcriptional control, and assemble an operably linked multiprotein complex. Expression program and cell fat.

References

1. Guttmacher AE, Collins FS. Welcome to the genomic era. NEJM. 2003;349(10):996-8.

Indexed at, Google Scholar, Cross Ref

2. Church GM, Gilbert W. Genomic sequencing. PNAS. 1984;81(7):1991-5.

Indexed at, Google Scholar, Cross Ref

3. Inoue K, Lupski JR. Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet. 2002;3(1):199-242.

Indexed at, Google Scholar, Cross Ref

4. Bouchard C. Genomic predictors of trainability. Exp Physiol. 2012;97(3):347-52.

Indexed at, Google Scholar, Cross Ref

5. Aslett M, Aurrecoechea C, Berriman M, et al. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res Spec Publ. 2010;38:D457-62.

Indexed at, Google Scholar, Cross Ref